Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Becattini

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
Duration of anticoagulant treatment after venous thromboembolismCecilia Becattini, Giancarlo Agnelli
Journal of Thrombosis and Thrombolysis|October 2, 2007
Treatment of DVT: how long is enough and how do you predict recurrenceGiancarlo Agnelli, Cecilia Becattini
Seminars in Thrombosis and Hemostasis|December 16, 2006
New anticoagulantsGiancarlo Agnelli, Cecilia Becattini
The European Respiratory Journal|January 13, 2017
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification modelCecilia Becattini, Giancarlo Agnelli
The European Respiratory Journal|February 21, 2015
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approachGiancarlo Agnelli, Cecilia Becattini
Internal and Emergency Medicine|February 13, 2015
Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? NoCecilia Becattini, Giancarlo Agnelli
Current Vascular Pharmacology|May 22, 2014
Long-term treatment of venous thromboembolismCecilia Becattini, Giorgia Manina
Journal of the American College of Cardiology|April 8, 2026
AHA/ACC Clinical Categories for Pulmonary Embolism: Reflections on the Progress and the Path ForwardCecilia Becattini, David Jiménez
Journal of Thrombosis and Thrombolysis|November 19, 2021
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopeniaGiorgio Maraziti, Cecilia Becattini
Thrombosis and Haemostasis|May 26, 2023
Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?Cecilia Becattini, Giancarlo Agnelli
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Pathophysiology of Haemostasis and Thrombosis|February 5, 2005
Duration of anticoagulant treatment after venous thromboembolismCecilia Becattini, Giancarlo Agnelli
Journal of Thrombosis and Thrombolysis|October 2, 2007
Treatment of DVT: how long is enough and how do you predict recurrenceGiancarlo Agnelli, Cecilia Becattini
Seminars in Thrombosis and Hemostasis|December 16, 2006
New anticoagulantsGiancarlo Agnelli, Cecilia Becattini
The European Respiratory Journal|January 13, 2017
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification modelCecilia Becattini, Giancarlo Agnelli
The European Respiratory Journal|February 21, 2015
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approachGiancarlo Agnelli, Cecilia Becattini
Internal and Emergency Medicine|February 13, 2015
Is there still a place for thrombolytic therapy in hemodynamically stable patients with acute pulmonary embolism? NoCecilia Becattini, Giancarlo Agnelli
Current Vascular Pharmacology|May 22, 2014
Long-term treatment of venous thromboembolismCecilia Becattini, Giorgia Manina
Journal of the American College of Cardiology|April 8, 2026
AHA/ACC Clinical Categories for Pulmonary Embolism: Reflections on the Progress and the Path ForwardCecilia Becattini, David Jiménez
Journal of Thrombosis and Thrombolysis|November 19, 2021
Eltrombopag for refractory vaccine-induced immune thrombotic thrombocytopeniaGiorgio Maraziti, Cecilia Becattini
Thrombosis and Haemostasis|May 26, 2023
Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?Cecilia Becattini, Giancarlo Agnelli
Pageof 25